Back to search
FDAFDA · Food and drugs·Recall number Z-1747-2025

FoundationOne Companion Diagnostic (F1CDx)

Published May 21, 2025 · Recall initiated: April 9, 2025

Summary

FDA records medical device Class II recall Z-1747-2025, published May 21, 2025 and initiated April 9, 2025. Recalling firm: Foundation Medicine, Inc.; Status: Ongoing; Reported quantity: 4 units; Lot: ORD-XXXXX28-01 ORD-XXXXX98-01 ORD-XXXXX29-01 ORD-XXXXX99-01 Note: The above characters have been redacted to minimize patient information disclosure. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Foundation Medicine, Inc.
Distributor
Worldwide - US Nationwide distribution in the states of GA, NY and the country of Russia.
Lot
ORD-XXXXX28-01 ORD-XXXXX98-01 ORD-XXXXX29-01 ORD-XXXXX99-01 Note: The above characters have been redacted to minimize patient information disclosure.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was FoundationOne Companion Diagnostic (F1CDx) recalled?

Yes. FDA published recall Z-1747-2025 on May 21, 2025. Reported hazard: Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter